Evaxion Encouraging Initial Phase 2 Data on Personalized Cancer Vaccine

 

• Initial EVX-01 Phase 2 data confirms the strong Phase 1 results

• After undergoing EVX-01 treatment, a significant and continuous tumor reduction was observed in a metastatic melanoma patient with initial progressive disease

https://www.biospace.com/article/releases/evaxion-announces-encouraging-initial-phase-2-clinical-data-on-its-personalized-cancer-vaccine-evx-01/